勒梅特血管

最新新闻

• 评级变动
  Roth MKM Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $108
  \u5e02\u573a\u8d44\u8baf · 2025/11/7
• Barrington Upgrades LeMaitre Vascular(LMAT.US) to Buy Rating, Maintains Target Price $95
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Roth MKM Initiates LeMaitre Vascular(LMAT.US) With Buy Rating, Announces Target Price $108
  \u5e02\u573a\u8d44\u8baf · 2025/11/5
• 评级变动
  Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $95
  \u5e02\u573a\u8d44\u8baf · 2026/2/20
• 评级变动
  A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $94 to $118
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• 评级变动
  A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $95 to $120
  \u5e02\u573a\u8d44\u8baf · 2025/11/8
• Stifel Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $120
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $105 to $124
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• Barrington Upgrades LeMaitre Vascular(LMAT.US) to Buy Rating, Announces Target Price $95
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• Barrington Downgrades LeMaitre Vascular(LMAT.US) to Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  Citizens JMP Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $127
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• KeyBanc Maintains LeMaitre Vascular(LMAT.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $120
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• 评级变动
  Wells Fargo Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Maintains Target Price $97
  \u5e02\u573a\u8d44\u8baf · 2025/8/27
• 评级变动
  Analysts' Opinions Are Mixed on These Healthcare Stocks: Zymeworks (ZYME), MBX Biosciences, Inc. (MBX) and Lemaitre Vascular (LMAT)
  TipRanks · 2025/11/7
• 评级变动
  A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $120 to $135
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (ARDT), Lemaitre Vascular (LMAT) and Gilead Sciences (GILD)
  TipRanks · 2026/6/3
• 评级变动
  Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $120
  \u5e02\u573a\u8d44\u8baf · 2026/6/3
• 评级变动
  Wells Fargo Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Cuts Target Price to $93
  \u5e02\u573a\u8d44\u8baf · 2025/11/26
• 评级变动
  Wells Fargo Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Maintains Target Price $93
  \u5e02\u573a\u8d44\u8baf · 2025/12/12

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。